SLU-PP-332
SLU-PP-332 is a synthetic small-molecule compound (sometimes classified alongside research peptides) that activates oestrogen-related receptors (ERRα, ERRβ, ERRγ). It has attracted significant attention as a potential 'exercise mimetic' — producing metabolic adaptations similar to endurance training without physical exertion.
Quick facts
- Half-life
- ~2–4 hours (estimated)
- Administration
- Subcutaneous injection
- Primary use
- Exercise mimetic, fat loss, metabolic enhancement
How it works
SLU-PP-332 activates ERR receptors, which regulate mitochondrial biogenesis, fatty acid oxidation, and oxidative metabolism in muscle tissue. In animal studies, it increased endurance capacity and promoted fat burning, mimicking the cellular adaptations of aerobic exercise.
Reported benefits
- Increased fat oxidation and metabolic rate
- Improved endurance capacity in preclinical models
- Mitochondrial biogenesis — more efficient energy production
- Potential utility for metabolic disease and obesity research
Typical dosing protocol
Dosing
Research protocols are not well established for humans; animal studies used ~30 mg/kg. Human dosing is speculative at this stage.
Cycle length
Not established — very early research stage
Dosing information is for educational reference only. Individual needs vary. Always consult a healthcare professional.
Safety & considerations
Extremely limited human data. This is a very early-stage research compound. Long-term safety is unknown. Not approved for human use in the UK. Consult a healthcare professional before use.
Important: All content is for informational purposes only. Not medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.